From Table 1, only three CEA levels in 24 breast patients and seven CA 15–3 levels in 24 breast cancer patients were higher than the cutoff value (sensitivity: CEA – 12.5% and CA 15–3 – 29.2%). Here, CEACAM5 is linked to breast cancer.